Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Concepción Morales García"'
Autor:
Matías Regiart, Martín A. Fernández-Baldo, Bernardino Alcázar Navarrete, Concepción Morales García, Beatriz Gómez, Gonzalo R. Tortella, Teresa Valero, Francisco Gabriel Ortega
Publikováno v:
Frontiers in Chemistry, Vol 12 (2024)
Lung cancer is the leading cause of cancer death in both men and women. It represents a public health problem that must be addressed through the early detection of specific biomarkers and effective treatment. To address this critical issue, it is imp
Externí odkaz:
https://doaj.org/article/9afd3c88845e49a389ee15acfdc7b112
Autor:
Juan Jiménez-Jáimez, Rosa Macías-Ruiz, Francisco Bermúdez-Jiménez, Ricardo Rubini-Costa, Jessica Ramírez-Taboada, Paula Isabel García Flores, Laura Gallo-Padilla, Juan Diego Mediavilla García, Concepción Morales García, Sara Moreno Suárez, Celia Fignani Molina, Miguel Álvarez López, Luis Tercedor
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-8 (2020)
Abstract SARS-CoV-2 is a rapidly evolving pandemic causing great morbimortality. Medical therapy with hydroxicloroquine, azitromycin and protease inhibitors is being empirically used, with reported data of QTc interval prolongation. Our aim is to ass
Externí odkaz:
https://doaj.org/article/0ddaaea59a564eee8cd88c0cb2f77917
Autor:
Eva María Triviño-Ibáñez, Beatriz María Jiménez-Rodríguez, Teodoro Rudolphi-Solero, Encarnación Yolanda García-Rivero, Antonio Rodríguez-Fernández, José Manuel Llamas-Elvira, Manuel Gómez-Río, Concepción Morales-García
Publikováno v:
Diagnostics, Vol 12, Iss 4, p 835 (2022)
SARS-CoV-2 virus infects organs other than the lung, such as mediastinal lymph nodes, spleen, and liver, but, to date, metabolic imaging studies obtained in short-term follow-ups of patients hospitalized with severe COVID-19 infection are rare. Our o
Externí odkaz:
https://doaj.org/article/860f8acfb4b242ceae1affab1ec81e6b
Autor:
Susana Rojo-Tolosa, José Antonio Sánchez-Martínez, Laura Elena Pineda-Lancheros, José María Gálvez-Navas, María Victoria González-Gutiérrez, Gonzalo Jiménez-Gálvez, Cristina Pérez-Ramírez, Concepción Morales-García, Alberto Jiménez-Morales
Publikováno v:
International Journal of Molecular Sciences; Volume 24; Issue 8; Pages: 7029
Omalizumab is a monoclonal antibody indicated for the treatment of severe uncontrolled asthma with an allergic phenotype. Its effectiveness could be influenced by clinical variables and single nucleotide polymorphisms (SNPs) in one or more of the gen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a83eeb0577498479277afe7d3b06f9b
https://hdl.handle.net/10481/82313
https://hdl.handle.net/10481/82313
Autor:
Susana Rojo-Tolosa, María Victoria González-Gutiérrez, José Antonio Sánchez-Martínez, Gonzalo Jiménez-Gálvez, Laura Elena Pineda-Lancheros, José María Gálvez-Navas, Alberto Jiménez-Morales, Cristina Pérez-Ramírez, Concepción Morales-García
Publikováno v:
Pharmaceutics
Volume 15
Issue 2
Pages: 523
Volume 15
Issue 2
Pages: 523
The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/pharmaceutics15020523/s1, Table S1: Predictors of oral corticosteroid reduction at 12 months of omalizumab treatment in patients with severe uncontrolled
Autor:
Susana Rojo-Tolosa, Laura Elena Pineda-Lancheros, José María Gálvez-Navas, José Antonio Sánchez-Martínez, María Victoria González-Gutiérrez, Andrea Fernández-Alonso, Concepción Morales-García, Alberto Jiménez-Morales, Cristina Pérez-Ramírez
Publikováno v:
Nutrients
Volume 15
Issue 4
Pages: 823
Volume 15
Issue 4
Pages: 823
Supplementary Materials: The following supporting information can be downloaded at: https:// www.mdpi.com/article/10.3390/nu15040823/s1, Table S1: Hardy-Weinberg equilibrium; Table S2: Linkage disequilibrium; Table S3: Minor allele frequencies of SNP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::520cc0bf08ce02ac0f4d8bbd096707a1
https://hdl.handle.net/10481/81049
https://hdl.handle.net/10481/81049
Autor:
Beatriz María Jiménez-Rodríguez, Eva Maria Triviño-Ibáñez, José Gutiérrez-Fernández, Ana Dolores Romero-Ortiz, Eldis Maria Ramos-Urbina, Concepción Morales-García
Publikováno v:
Healthcare; Volume 10; Issue 12; Pages: 2341
Respiratory function deficits are common sequelae for COVID-19. In this study, we aimed to identify the medical conditions that may influence lung function impairment at 12 months after SARS-CoV2 infection and to analyze the role of alpha-1 antytrips
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12c185fd53b60177b59c344619556216
https://hdl.handle.net/10481/79412
https://hdl.handle.net/10481/79412
Autor:
Susana Rojo-Tolosa, María Victoria González-Gutiérrez, Gonzalo Jiménez-Gálvez, José Antonio Sánchez-Martínez, Laura Elena Pineda-Lancheros, José María Gálvez-Navas, Alberto Jiménez-Morales, Cristina Pérez-Ramírez, Concepción Morales-García
Publikováno v:
International Journal of Molecular Sciences
Volume 24
Issue 3
Pages: 2011
Volume 24
Issue 3
Pages: 2011
Severe Uncontrolled Asthma (SUA) counts for more than 25% of cases of severe asthma. The main factors that impair the quality of life of these patients are high doses of oral corticosteroids, the presence of exacerbations, and reduced lung function.
Autor:
Eldis Maria Ramos Urbina, Maria Inmaculada Santiago Puertas, Genaro López Milena, Concepción Morales García, Maria Jose Martín López, Ana Dolores Romero Ortiz, Beatriz Maria Jiménez Rodríguez, Rene Fabregas, Paula Isabel García Flores, José Gutiérrez Fernández
Publikováno v:
Digibug. Repositorio Institucional de la Universidad de Granada
instname
instname
Medical research is progressing to clarify the full spectrum of sub-acute and long-term effects of post-acute sequelae of COVID-19. However, most manuscripts published to date only analyze the effects of long COVID in patients discharged from hospita
Autor:
Alicia Padilla-Galo, Ana P. Gómez-Bastero Fernández, Gustavo Villegas Sánchez, Alberto Levy, Francisco Gutiérrez, Concepción Morales-García, Luis Mateos Caballero, Juan José Martín Villasclaras, Cayo García Polo, Gerardo Pérez Chica, Rocío Gallego Domínguez, José Gregorio Soto Campos, Antonio Pereira-Vega, Luis Manuel Entrenas Costa, Francisco Casas-Maldonado
Publikováno v:
PharmacoEconomics Open
Background Omalizumab is a fully humanized monoclonal antibody indicated as add-on therapy to improve asthma control in patients with severe persistent allergic asthma. Aims The aim of this study was to evaluate social, healthcare expenditure and cli